Genentech, Inc. - Company & Market Research Reports

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.


Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors - Product Thumbnail Image

Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors

  • Report
  • 70 Pages
From
Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021 - Product Thumbnail Image

Remicade Biosimilar Market: By Type, By Technology, By Service, By Application, By Region - Forecast 2016-2021

  • Report
  • 146 Pages
From
Investigation Report on China's Bevacizumab Market ,2010-2019 - Product Thumbnail Image

Investigation Report on China's Bevacizumab Market ,2010-2019

  • Report
  • 20 Pages
From
Investigation Report on China Bevacizumab Market, 2009-2018 - Product Thumbnail Image

Investigation Report on China Bevacizumab Market, 2009-2018

  • Report
  • 40 Pages
From
Investigation Report on China Adalimumab Market, 2010-2018 - Product Thumbnail Image

Investigation Report on China Adalimumab Market, 2010-2018

  • Report
  • 40 Pages
From
Rituxan 2016 U.S Promotional Report - Product Thumbnail Image

Rituxan 2016 U.S Promotional Report

  • Report
  • 27 Pages
From
Drug analysis: Avastin - Product Thumbnail Image

Drug analysis: Avastin

  • Drug Pipelines
  • 116 Pages
From
Avastin 2016 U.S Promotional Report - Product Thumbnail Image

Avastin 2016 U.S Promotional Report

  • Report
  • 25 Pages
From
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market - Product Thumbnail Image

Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market

  • Report
  • 131 Pages
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2018

  • Report
  • 47 Pages
From
Therapy Class Overview : Rituximab biosimilar - Product Thumbnail Image

Therapy Class Overview : Rituximab biosimilar

  • Report
  • 45 Pages
From
Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H1 2018 - Product Thumbnail Image

Tyrosine Protein Kinase ITK/TSK (Interleukin 2 Inducible T Cell Kinase or T Cell Specific Kinase or Kinase EMT or Tyrosine Protein Kinase Lyk or ITK or EC 2.7.10.2) - Pipeline Review, H1 2018

  • Report
  • 56 Pages
From
Bladder and Ureter Cancer Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Bladder and Ureter Cancer Drug Development Pipeline Review, 2017

  • Report
  • 150 Pages
From
Tarceva 2016 U.S Promotional Report - Product Thumbnail Image

Tarceva 2016 U.S Promotional Report

  • Report
  • 21 Pages
From
Global Genetic Testing Market – Industry Analysis And Market Forecast (2016 - 2021) - Product Thumbnail Image

Global Genetic Testing Market – Industry Analysis And Market Forecast (2016 - 2021)

  • Report
  • 139 Pages
From
Gouty Arthritis (Gout) - Pipeline Review, H1 2018 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H1 2018

  • Report
  • 99 Pages
From
Breast Cancer: New targeted therapies transform treatment - KOL Insight - Product Thumbnail Image

Breast Cancer: New targeted therapies transform treatment - KOL Insight

  • Report
  • 153 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2021 - Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Drug Pipelines
  • 682 Pages
From
Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - Product Thumbnail Image

Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries

  • Report
  • 682 Pages
From
Psoriasis Treatments 2012-2013 Patent Landscape - Product Thumbnail Image

Psoriasis Treatments 2012-2013 Patent Landscape

  • Report
  • 82 Pages
From
Loading Indicator
adroll